Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

July 31, 2016

Conditions
Type 1 Diabetes
Interventions
DEVICE

ePID closed loop system

Insulin pump controlled by closed loop unit and algorithm

DRUG

hyaluronidase

DRUG

Lispro-PH20

Trial Locations (1)

06520

Yale University School of Medicine, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT01945099 - Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy | Biotech Hunter | Biotech Hunter